pharmacyclics8kaug72014.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
 
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): August 7, 2014
 
PHARMACYCLICS, INC.
(Exact Name of Registrant as specified in Charter)
 
Delaware
000-26658
94-3148201
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
995 E. Arques Avenue, Sunnyvale, California
94085-4521
(Address of Principal Executive Offices)
(Zip Code)
 
Registrant’s telephone number, including area code: (408) 774-0330
 
 
(Former Name or Former Address, if Changed Since Last Report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 8.01
Other Events.
 
    Pharmacyclics, Inc. (the “Company”) announced the transition of Dr. Jesse McGreivy from his current position of Chief Medical Officer to that of a senior advisor to the Company. As of August 7, 2014, Dr. McGreivy will provide advisory services to the Company for a period of up to six months. Dr. McGreivy has initiated this transition for personal reasons. We thank Dr. McGreivy for his accomplishments as well as his support in building the clinical science team, which today consists of strong leaders in each disease area.

 
 
 

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
 
August 8, 2014
 
  PHARMACYCLICS, INC.  
       
       
  By: /s/ Manmeet Soni  
    Name: Manmeet Soni  
    Title: Chief Financial Officer